MAPT and Alzheimer disease: Accordingly, an analysis of 40 patients revealed that individuals presenting lower levels of plasma β-carotene showed increased concentrations of Aβ1–42 and total tau in the cerebrospinal fluid (CSF), thus linking peripheral β-carotene to established neurochemical AD markers [43].